REBORN
A digital patient education innovation designed to explain oncoplastic reconstruction and support clearer treatment conversations.
03Breast conservation innovation
Build technology around a real surgical need.
Clement’s clinician-led innovation platform asks how technology can help more suitable women preserve the breast, avoid unnecessary re-operation, understand their choices and recover with better quality of life.
Margin assessment
Intra-operative technologies intended to identify cancer at the specimen edge and address re-excision after breast-conserving surgery.
Surgical devices
Low-thermal electrosurgical development focused on tissue effects in breast-conserving and oncoplastic surgery.
Industry collaboration areas
A translational test bed for breast conservation.
01
Intra-operative margin assessment
02
Imaging and surgical guidance
03
Low-thermal and tissue-preserving devices
04
Digital health and patient education
05
PROMs and outcome measurement
06
Clinical AI and decision support
07
Clinical implementation
08
Real-world validation pathways
Clinician-led translation
From unmet need and early validation to implementation in real clinical pathways.
01
Define a meaningful patient or workflow problem
02
Co-design with patients and multidisciplinary clinical teams
03
Generate the evidence appropriate to the technology and claim
04
Test usability, integration and implementation in context
05
Translate responsibly with academic, A*STAR and industry partners
For medtech partners
New tools must be evaluated for safety, usefulness, workflow fit and clinical value. Innovation does not guarantee improved outcomes.